These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11111187)

  • 1. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
    Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A
    Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
    Okubo K; Ishitoya S; Maeda H; Suzuki Y; Arai Y
    Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):386-90. PubMed ID: 9125861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.
    Miyake H; Eto H; Hara S; Okada H; Kamidono S; Hara I
    Int J Urol; 2002 Dec; 9(12):677-80. PubMed ID: 12492951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract.
    Nishino Y; Yamamoto N; Komeda H; Takahashi Y; Deguchi T
    BJU Int; 2000 May; 85(7):799-801. PubMed ID: 10792155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
    Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy.
    Kojima Y; Tozawa K; Kawai N; Sasaki S; Hayashi Y; Kohri K
    Int J Urol; 2006 Apr; 13(4):340-4. PubMed ID: 16734847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    Thalmann GN; Markwalder R; Walter B; Studer UE
    J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
    Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M
    J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.
    Sharpe JR; Duffy G; Chin JL
    J Urol; 1993 Mar; 149(3):457-9; discussion 459-60. PubMed ID: 8437246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter.
    Irie A; Iwamura M; Kadowaki K; Ohkawa A; Uchida T; Baba S
    Urology; 2002 Jan; 59(1):53-7. PubMed ID: 11796281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure.
    Okubo K; Ichioka K; Terada N; Matsuta Y; Yoshimura K; Arai Y
    BJU Int; 2001 Sep; 88(4):343-7. PubMed ID: 11564018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCG.
    Miller EB; Eure GR; Schellhammer PF
    Urology; 1993 Jul; 42(1):26-30. PubMed ID: 8328123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcome of intrarenal Bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
    Anan G; Suyama T; Takeuchi N; Nakamura K; Sakamoto S; Nihei N; Ichikawa T
    Hinyokika Kiyo; 2013 May; 59(5):261-4. PubMed ID: 23719131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
    Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma.
    Patel A; Fuchs GJ
    J Urol; 1998 Jan; 159(1):71-5. PubMed ID: 9400440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
    Shimasaki N; Yamasaki I; Kamada M; Syuin T
    Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of intravesical bacillus Calmette-Guérin therapy with maintenance for urinary bladder carcinoma in situ: About 47 cases.
    Sallami S; Khouni H; Ben Atta M; Abou El Makarim S; Zouari MB; Ben Rhouma S
    Tunis Med; 2016 Dec; 94(12):844. PubMed ID: 28994883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.